Filter By Category
Archives
Share on -
AVIBACTAM
Generic Name: AVIBACTAM
ABSTRACT -
Avibactam is a non-beta-lactam beta-lactamase inhibitor used in approved antibacterial combinations to restore activity against selected beta-lactamase-producing organisms. Its molecular formula is C₇H₁₁N₃O₆S. The chemical representation above shows the 2D skeletal structure.
This document is for structured API information only. It is not a prescribing guide. Clinical use, if any, must follow the approved local label, trial protocol, and specialist medical supervision.
DOSAGE -
- Dosage should be determined only by a qualified healthcare professional.
- Use only according to the approved local product label and institutional administration procedures.
- Infusion or injection settings must have monitoring and emergency support as required for the product class.
- Do not administer outside authorized indications or specialist supervision.
SIDE EFFECTS-
Possible side effects and safety concerns include:
- Nausea, vomiting, diarrhea, abdominal pain, or constipation
- Headache, dizziness, infusion-site reaction, or rash
- Elevated liver enzymes or renal laboratory changes may occur
- Clostridioides difficile-associated diarrhea is a risk with antibacterial therapy
- Seizures or neurotoxicity may occur especially with renal impairment and beta-lactam combinations
ALLERGIC REACTIONS -
Hypersensitivity to Avibactam or related compounds/products may occur. Symptoms may include:
- Immediate urticaria, itching, flushing, or generalized rash
- Facial, lip, tongue, or throat swelling
- Wheezing, chest tightness, or breathing difficulty
- Dizziness, fainting, severe hypotension, or collapse
- Anaphylaxis, although uncommon, requires emergency medical treatment
Important: Patients who develop an allergic reaction to Avibactam should seek immediate medical attention and inform all future healthcare providers of the allergy.
DRUG INTERACTIONS-
Avibactam may interact with certain medicines, biologics, vaccines, protocols, or clinical conditions. Caution is needed with:
- Dose adjustment may be required with renal impairment for avibactam-containing combinations.
- Probenecid or medicines affecting renal tubular secretion may alter beta-lactam exposure.
- Other nephrotoxic or neurotoxic medicines require monitoring.
- Patients should report all antibiotics, medicines, and supplements.
Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, vaccines, and supplements they are using.
PREAUTIONS–
- Use only for infections where the selected combination is appropriate.
- Review culture, susceptibility, renal function, and allergy history.
- Monitor for severe diarrhea, hypersensitivity, and neurologic symptoms.
- Antimicrobial stewardship principles should be followed.
WARNINGS –
- Serious hypersensitivity and C. difficile-associated diarrhea can occur.
- Incorrect dosing in renal impairment may increase toxicity or reduce effectiveness.
- Use only under medical supervision for bacterial infections.
- Keep out of reach of children.
Share on -
. Developed by